Shenzhen - Delayed Quote CNY

Shandong Xinhua Pharmaceutical Company Limited (000756.SZ)

15.62 +0.19 (+1.23%)
As of 2:22 PM GMT+8. Market Open.
Loading Chart for 000756.SZ
DELL
  • Previous Close 15.43
  • Open 15.31
  • Bid 15.61 x --
  • Ask 15.62 x --
  • Day's Range 15.36 - 15.80
  • 52 Week Range 13.45 - 27.99
  • Volume 7,219,350
  • Avg. Volume 9,577,646
  • Market Cap (intraday) 8.588B
  • Beta (5Y Monthly) -0.01
  • PE Ratio (TTM) 21.69
  • EPS (TTM) 0.72
  • Earnings Date Apr 19, 2024 - Apr 22, 2024
  • Forward Dividend & Yield 0.20 (1.30%)
  • Ex-Dividend Date Jul 26, 2023
  • 1y Target Est --

Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally. The company offers antipyretic and analgesic drugs; cardiovascular and cerebrovascular drugs; anti-infective drugs and central nervous drugs; and other drugs. It engages in the development of real estate business. Shandong Xinhua Pharmaceutical Company Limited was founded in 1943 and is based in Zibo, the People's Republic of China.

www.xhzy.com

7,104

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 000756.SZ

Performance Overview: 000756.SZ

Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

000756.SZ
23.36%
SSE Composite Index
2.42%

1-Year Return

000756.SZ
43.68%
SSE Composite Index
6.98%

3-Year Return

000756.SZ
85.46%
SSE Composite Index
12.30%

5-Year Return

000756.SZ
93.57%
SSE Composite Index
4.84%

Compare To: 000756.SZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 000756.SZ

Valuation Measures

Annual
As of 4/25/2024
  • Market Cap

    8.48B

  • Enterprise Value

    8.92B

  • Trailing P/E

    21.43

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.31

  • Price/Book (mrq)

    2.31

  • Enterprise Value/Revenue

    1.10

  • Enterprise Value/EBITDA

    8.21

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.13%

  • Return on Assets (ttm)

    3.87%

  • Return on Equity (ttm)

    11.09%

  • Revenue (ttm)

    8.1B

  • Net Income Avi to Common (ttm)

    496.51M

  • Diluted EPS (ttm)

    0.72

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    918.33M

  • Total Debt/Equity (mrq)

    28.45%

  • Levered Free Cash Flow (ttm)

    50.07M

Company Insights: 000756.SZ

People Also Watch